Catalyst Biosciences
CBIO • XNAS
Catalyst Biosciences is a publicly traded company trading on XNAS, led by CEO Joshua T. Brumm, with a market cap of $581.5M.
Market Cap$581.5M
Employees7.0
CEOJoshua T. Brumm
CountryUnited States of America
Next EarningsMay 23, 2026 · in a monthQ1 2026
Financials
CBI
Catalyst Biosciences FAQ
Common questions about Catalyst Biosciences
Catalyst Biosciences is scheduled to report earnings for Q1 2026 on May 23, 2026. Analysts estimate revenue of $357.1K.
Catalyst Biosciences has approximately 7 employees.